Schmarsow R
Rofo. 1976 Apr;124(4):310-4. doi: 10.1055/s-0029-1230337.
Angiography before and after the administration of Glucagon was performed in 33 adult patients with symptoms suggesting a pancreatic lesion. Preferently the pancreatographic effect was evaluated. The results were compared with those of the angiography following the administration of Secretin and Tolazoline. The pancreatographic effect was visualized in 70% of the patients examined with Glucagon and the rate of visualization of the effect with Secretin and Tolazoline was 60% and 74.5% respectively. The representation of the small vessels could be enhanced with Glugacon only in 15% for the arteries and in 12.5% for the veins, whereas using Secretin and Tolazoline the improvement raised up to 78% of the cases. -- The pancreatographic effect as an additional sign is useful in the differential diagnosis of the chronic pancreatitis (mottled) and the carcinoma of the pancreas (defect or absence of the effect).-- The superselective technique is recommendable. Using this method an improvement of the pancreatographic effect can be achieved already. In pharmacoangiography Tolazoline gives better results than Glucagon.
对33例有胰腺病变症状的成年患者在注射胰高血糖素前后进行了血管造影。优先评估胰管造影效果。将结果与注射促胰液素和妥拉唑啉后的血管造影结果进行比较。用胰高血糖素检查的患者中70%观察到胰管造影效果，用促胰液素和妥拉唑啉观察到效果的比例分别为60%和74.5%。仅用胰高血糖素时，小血管显示增强的比例动脉为15%，静脉为12.5%，而使用促胰液素和妥拉唑啉时，改善比例高达78%。——胰管造影效果作为一个附加征象，在慢性胰腺炎（斑点状）和胰腺癌（效果缺损或无效果）的鉴别诊断中有用。——推荐采用超选择性技术。使用这种方法已经可以实现胰管造影效果的改善。在药物血管造影中，妥拉唑啉比胰高血糖素效果更好。
